Trading Update

In brief · summary, not quotable

Feedback plc reported revenue of approximately £0.4 million for the six months ending 30 November 2025, consistent with the prior year's first half, and maintains sufficient cash runway through mid-2027. The company notes a stabilising NHS backdrop with increased policy focus on technology and digitisation to reduce waiting times, positioning its Bleepa platform to benefit from this trend and potential sales momentum building around the next tax year. Management anticipates a new phase of commercialisation driven by NHS spending review funding for 2026/27 and growing recognition of technology's role in healthcare.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your FDBK notes

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, provides a trading update for the six months to 30 November 2025 (the "Period").

Revenue for the Period is expected to be c. £0.4m (H1 2025: £0.4m). Cash outlook remains in line with expectations and the Company continues to have sufficient cash runway through to mid-2027.

The backdrop is stabilising after last year's uncertainty and disruption across the NHS. During the Period there has been increased focus from policy makers and NHS management on the role of technology and digitisation in reducing NHS waiting times, combined with moves towards neighbourhood healthcare. This is supported by commitments to increase NHS technology spend.

Bleepa is well positioned given its proven capabilities and capacity to address analogue to digital and facilitate hospital to community, combined with its ability to help reduce waiting lists. As last year's disruption passes and given the increasing focus on technology and the flexibility of the Company's solutions, management expects that sales momentum could build around the next tax year, with the Company positioned to scale quickly and effectively.

Dr Tom Oakley, CEO of Feedback plc, said: "The 10-year plan and direction of travel of the NHS are clearly aligned with the solutions we provide. Spending Review funding is due to be released to the NHS frontline for 2026/27, and we believe that this combined with an increasing recognition of the role of technology in healthcare will drive a new phase of commercialisation for Feedback."

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.